Efficacy of perioperative parecoxib injection on postoperative pain relief after exploratory laparotomy for gynaecologic surgery

Efficacy of perioperative parecoxib injection on postoperative pain relief after exploratory laparotomy for gynaecologic surgery : Double-blind randomized controlled clinical trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

TCTR

Registry ID

TCTR20140523001

Enrollment

Unknown

Registered

2014-05-23

Start date

2013-10-06

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

allergy and side effect of parecoxib in this study.

Interventions

received parecoxib 40 mg at 1 hr before surgery.,received placebo at 1 hr before surgery.

parecoxib group,placebo group

Eligibility

Sex/Gender

Female

Age

20 Years to 60 Years

Inclusion criteria

Inclusion criteria: elective exploratory lapararotomy for gynaecologic surgery between January to December 2013 were recruited Written inform consent was signed after patient understood the proposal well from a thorough counselling

Exclusion criteria

Exclusion criteria: Underlying disease of cardiovascular renal hepatic diseases bleeding disorder hypersensitivity to NSAIDs

Design outcomes

Primary

Measure	Time frame
efficacy of parecoxib for postoperative pain relief after exploratory laparotomy for gynaecological one year Patient reported outcome using a questionnaire interview	—

Secondary

Measure	Time frame
frequency of meperidine 24 hrs consumption and side effect of parecoxib were recorded one year Patient reported outcome using a questionnaire interview	—

Countries

Thailand.

Contacts

Public Contactpawat Arponrat

Thammasat hospital

num_md@yahoo.co.th0812095395

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026